Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India

被引:67
|
作者
Alvarez-Uria, Gerardo [1 ]
Naik, Praveen K. [1 ]
Pakam, Raghavakalyan [1 ]
Midde, Manoranjan [1 ]
机构
[1] Rural Dev Trust Hosp, Dept Infect Dis, Bathalapalli, India
关键词
developing countries; rural health; highly active antiretroviral therapy; lost to follow up; attrition; mortality; RISK-FACTORS; PROGRAMS; INFECTION; RETENTION; DIAGNOSIS; OUTCOMES; WOMEN;
D O I
10.3402/gha.v6i0.21682
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Studies from sub-Saharan Africa have shown high incidence of attrition due to mortality or loss to follow-up (LTFU) after initiating antiretroviral therapy (ART). India is the third largest country in the world in terms of HIV infected people, but predictors of attrition after ART initiation are not well known. Design: We describe factors associated with attrition, mortality, and LTFU in 3,159 HIV infected patients who initiated ART between 1 January 2007 and 4 November 2011 in an HIV cohort study in India. The study included 6,852 person-years with a mean follow-up of 2.17 years. Results: After 5 years of follow-up, the estimated cumulative incidence of attrition was 37.7%. There was no significant difference between attrition due to mortality and attrition due to LTFU. Having CD4 counts < 100 cells/mu l and being homeless [adjusted hazard ratio (aHR) 3.1, 95% confidence interval (CI) 2.6-3.8] were associated with a higher risk of attrition, and female gender (aHR 0.64, 95% CI 0.6-0.8) was associated with a reduced risk of attrition. Living near a town (aHR 0.82, 95% CI 0.7-0.999) was associated with a reduced risk of mortality. Being single (aHR 1.6, 95% CI 1.2-2.3), illiteracy (aHR 1.3, 95% CI 1.1-1.6), and age < 25 years (aHR 1.3, 95% CI 1-1.8) were associated with an increased risk of LTFU. Although the cumulative incidence of attrition in patients diagnosed with tuberculosis after ART initiation was 47.4%, patients who started anti-tuberculous treatment before ART had similar attrition to patients without tuberculosis (36 vs. 35.2%, P = 0.19) after four years of follow-up. Conclusions: In this cohort study, the attrition was similar to the one found in sub-Saharan Africa. Earlier initiation of ART, improving the diagnosis of tuberculosis before initiating ART, and giving more support to those patients at higher risk of attrition could potentially reduce the mortality and LTFU after ART initiation.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy
    Schepens, T.
    Morreel, S.
    Florence, E.
    Koole, O.
    Colebunders, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (11) : 765 - 769
  • [22] Mortality Among Adults Transferred and Lost to Follow-up From Antiretroviral Therapy Programmes in South Africa: A Multicenter Cohort Study
    Cornell, Morna
    Lessells, Richard
    Fox, Matthew P.
    Garone, Daniela B.
    Giddy, Janet
    Fenner, Lukas
    Myer, Landon
    Boulle, Andrew
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : E67 - E75
  • [23] Patient Loss to Follow-Up Before Antiretroviral Therapy Initiation in Rural Mozambique
    da Silva, Monica
    Blevins, Meridith
    Wester, C. William
    Manjolo, Jose
    Jose, Eurico
    Gonzalez, Lazaro C.
    Shepherd, Bryan E.
    Moon, Troy D.
    Vaz, Lara M. E.
    AIDS AND BEHAVIOR, 2015, 19 (04) : 666 - 678
  • [24] Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation
    Lee, Jennifer S.
    Cole, Stephen R.
    Richardson, David B.
    Dittmer, Dirk P.
    Miller, William C.
    Moore, Richard D.
    Kitahata, Mari
    Mathews, Christopher
    Mayer, Kenneth
    Geng, Elvin
    Achenbach, Chad J.
    Eron, Joseph J., Jr.
    AIDS, 2017, 31 (14) : 1989 - 1197
  • [25] Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya
    Wekesa, P.
    McLigeyo, A.
    Owuor, K.
    Mwangi, J.
    Ngugi, E.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [26] A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
    Jose, Sophie
    Delpech, Valerie
    Howarth, Alison
    Burns, Fiona
    Hill, Teresa
    Porter, Kholoud
    Sabin, Caroline A.
    LANCET HIV, 2018, 5 (06): : E301 - E308
  • [27] Loss to Follow-Up and Mortality Rates in HIV-1-Infected Patients in Curacao Before and After the Start of Combination Antiretroviral Therapy
    Hermanides, Hillegonda
    Holman, Rebecca
    Gras, Luuk
    Winkel, Carel
    Gerstenbluth, Izzy
    de Wolf, Frank
    Duits, Ashley
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (10) : 1300 - 1305
  • [28] Factors associated to loss of follow-up in patients underwent antiretroviral therapy in an ambulatory HIV treatment center at Conakry
    Toure, A.
    Cisse, D.
    Kadio, K. J. J. O.
    Camara, A.
    Traore, F. A.
    Delamou, A.
    Sidide, S.
    Kouyate, C.
    Bangoura, I. S.
    Diallo, M. M.
    Tounkara, T. M.
    Traore, F.
    Sow, M. S.
    Khanafer, N.
    Cisse, M.
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2018, 66 (04): : 273 - 279
  • [29] Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis
    Van Cutsem, Gilles
    Ford, Nathan
    Hildebrand, Katherine
    Goemaere, Eric
    Mathee, Shaheed
    Abrahams, Musaed
    Coetzee, David
    Boulle, Andrew
    PLOS ONE, 2011, 6 (02):
  • [30] Loss to Follow-Up from HIV Screening to ART Initiation in Rural China
    Gu, Diane
    Mao, Yurong
    Tang, Zhenzhu
    Montaner, Julio
    Shen, Zhiyong
    Zhu, Qiuying
    Detels, Roger
    Jin, Xia
    Xiong, Ran
    Xu, Juan
    Ling, Walter
    Erinoff, Lynda
    Lindblad, Robert
    Liu, David
    Van Veldhuisen, Paul
    Hasson, Albert
    Wu, Zunyou
    PLOS ONE, 2016, 11 (10):